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Abstract Rationale: Nicotine is reported to improve
learning and memory in experimental animals. Improved
learning and memory has also been related to increased
neurogenesis in the dentate gyrus (DG) of the hippo-
campal formation. Surprisingly, recent studies suggest that
self-administered nicotine depresses cell proliferation in
the DG. Objective: To test the hypothesis that the effects
of nicotine on cell proliferation in the DG and learning and
memory depend upon the nicotine dose administered.
Methods: Rats were chronically infused from subcutane-
ous osmotic mini pumps with nicotine (0.25 or 4 mg kg−1
day−1) or the saline vehicle for 10 days. Half the rats in
each treatment group were trained to locate a hidden plat-
form in a water maze task on days 4–7; a probe trial was
performed on day 8. The remaining rats remained in their
home cages. The effects of nicotine and of training in the
water maze task on cell genesis in the DG were determined
bymeasuring 5-bromo-2′-deoxyuridine (BrdU) uptake using
fluorescence immunohistochemistry. Results: Training in
the water maze task increased cell proliferation in the DG.
Infusions of nicotine at 4 mg kg−1 day−1, but not 0.25 mg
kg−1 day−1, decreased cell proliferation in both untrained
animals and animals trained in the maze and impaired
spatial learning. Conclusions: The data suggest that learn-
ing in the water maze task is impaired by higher doses of
nicotine tested, and that this response may be related to
reduced cell genesis in the DG.
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Introduction
There is evidence from both clinical and preclinical stud-
ies that nicotine elicits improvements in cognitive func-
tion (Warburton and Rusted 1993; Hahn et al. 2002; Levin
and Rezvani 2002), and it has been suggested that these
effects contribute to the reinforcing properties of the drug
sought by smokers (Heishman 1999). The effects on cog-
nitive function are thought to be related to stimulation of
neurotransmitter systems within areas of the brain that
are important for cognitive processing (Levin and Simon
1998; Singer et al. 2004). As a result, nicotine and nicotin-
ic drugs have been explored for their efficacy as putative
treatments for the impaired cognitive function experienced
by patients with conditions such as Alzheimer’s disease
(Changeux et al. 1998; Picciotto and Zoli 2002).
The hippocampus is thought to play a pivotal role in
learning and memory, particularly in spatial learning
(Morris et al. 1982; Jacobs and Schenk 2003). The sub-
granular zone of the dentate gyrus (DG) within the hip-
pocampal formation is one of the few areas of the brain
in which neurogenesis continues to occur into adulthood
(Altman 1962; Eriksson et al. 1998). Increased neurogen-
esis can be produced by a variety of treatments, including
an enriched environment (Brown et al. 2003), physical
activity (van Praag et al. 1999) and antidepressant drugs
(Malberg et al. 2000; Santarelli et al. 2003). Neurogenesis
has also been specifically implicated in learning tasks that
involve the hippocampus. If rats are trained on a hippocam-
pal-dependent associative task, the survival of newborn
cells is increased (Gould et al. 1999), whereas performance
is impaired by an inhibition of cell proliferation (Shors
et al. 2001). It is therefore surprising that a recent study
found that self-administered nicotine decreased neurogen-
esis in this area of the brain (Abrous et al. 2002), a response
that appears inconsistent with the reported cognitive-en-
hancing properties of nicotine.
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This study investigated the effects of constantly infused
nicotine on spatial learning in the Morris water maze and
cell proliferation in the DG. Two doses of nicotine were
selected to permit a comparison of the effects of nicotine
over doses that have some relevance to the tobacco smok-
ing habit but exert different effects at the receptor level.
The high dose chosen (4 mg kg−1 day−1) results in blood
nicotine concentrations (approximately 80 ng/ml) that
would only be found in heavy smokers (Benwell et al.
1995) and desensitises many of the neuronal nicotinic re-
ceptors in the brain through which nicotine exerts its effects
(Benwell et al. 1995; Pidoplichko et al. 1997). The low-
er dose (0.25 mg kg−1 day−1) maintains a blood nicotine
concentration (approximately 8 ng/ml) commonly found in
the plasma of light smokers and does not desensitise these
receptors (Benwell et al. 1995).
Materials and methods
Subjects
Male Sprague–Dawley rats (Harlan Industries, UK) weigh-
ing 270–340 g at the start of the experiment were used.
Rats were housed, three per cage, in a temperature-con-
trolled (21°C) and humidity-controlled (50±10%) environ-
ment on a 12-h light/dark cycle, with lights on at 6:00 am.
Food and water were provided ad libitum. All the exper-
iments were conducted during the light phase of the cycle
and were in accordance with UK Home Office regula-
tions and covered by Home Office project licence number
60/2845.
Drug treatment
Rats were divided into three groups: a control group that
received saline, a low-dose group that received 0.25 mg/kg
nicotine per day (LDN) and a high-dose group that re-
ceived 4 mg/kg nicotine per day (HDN) (Table 1). All rea-
gents were purchased from commercially available sources
unless otherwise indicated. Nicotine or saline was admin-
istered subcutaneously via osmotic mini pump. (−)-Nico-
tine hydrogen tartrate (Sigma, UK) was dissolved in 0.9%
saline solution. The doses of nicotine were calculated as
those of the free base. Before filling the osmotic mini
pumps, drug solutions and vehicle were sterilised by fil-
tration through a 20-μm filter.
Osmotic mini pumps (Alzet, ALZA Corporation, Palo
Alto, CA, USA) were filled with drug or vehicle as in-
structed by the manufacturer. They were implanted subcu-
taneously (s.c.) in the flank under inhalational anaesthesia
(5% halothane for induction, 3% for maintenance) through
a small incision on the back at the level of the shoulders
on day 1 of the experiment. After a 2-day recovery period,
half of the rats were assigned to receive spatial training
(ST), and the other half remained in their home cage
(NST; no spatial learning).
Spatial learning task
Rats were trained in an open-field water maze (Morris
1984) that was 1.8 m in diameter and 0.6 m deep filled to
30 cm with water (26±2°C). The water was made opaque
by the addition of reconstituted milk powder, and various
extra maze cues were illuminated from below the level of
the maze using floodlights. Rats were trained for 4 days to
find an escape platform (10 cm diameter) hidden 2 cm
below the surface of the water. For half of the rats the
platform was located in the north-east quadrant, and for the
other half, in the south-west quadrant (see Fig. 1c). Every
day, rats in the ST groups were given two blocks of training
composed of four trials each. The two blocks of training
were separated by a 3-h interval. Eight different starting
points were used in a pseudorandom order. A maximum
search time of 120 s was allowed for each trial. If the rats
found the platform during this period, they were left on
the platform for 30 s before beginning the next trial. If any
rat failed to find the platform, it was placed on the plat-
form and again left for 30 s. On the day following the last
day of training, a probe trial was conducted to assess re-
tention of the platform location where the platform was
removed and each rat was allowed to swim for 60 s. The
rats were tracked using an overhead video camera. The
analogue signal was digitised (Hawk V10, Wild Vision) by
computer (Acorn A5000) to allow offline analysis (Water-
Maze software, University of Edinburgh). Performance
Table 1 Experimental protocol
Drug Treatment Days 4–7 Days 5–7 Day 8 Day 10
Saline NST BrdU Home cage Transcardial perfusion
Saline ST BrdU Probe trial Transcardial perfusion
Nicotine (0.25 mg kg−1 day−1) NST BrdU Home cage Transcardial perfusion
Nicotine (0.25 mg kg−1 day−1) ST BrdU Probe trial Transcardial perfusion
Nicotine (4 mg kg−1 day−1) NST BrdU Home cage Transcardial perfusion
Nicotine (4 mg kg−1 day−1) ST BrdU Probe trial Transcardial perfusion
Mini pumps containing nicotine or its saline vehicle were inserted
on day 1 of the experiment. The animals trained in the water maze
task (ST) following the procedure described in the Materials and
methods section. Untrained controls (NST groups) remained in their
home cages. On day 8, a probe trial was performed in the animals
trained on the spatial learning task. The animals were transcardially
perfused on day 10 and the brains removed for processing
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during task acquisition was assessed from escape latencies
(time taken to find the platform). Swim speeds were cal-
culated by dividing the distance travelled on each trial by
the time taken to find the platform. For the probe trial, the
computer calculated the percentage time spent in four
equal quadrants of the water maze and the number of times
rats swam over the exact position of the platform (annulus
crossings).
Measurement of bromodeoxyuridine incorporation
Cells formed from dividing progenitors were identified
using bromodeoxyuridine (BrdU) (Sigma, UK), which in-
tegrates into DNA during the S phase of DNA synthesis
(Cooper-Kuhn and Kuhn 2002). BrdU was dissolved in
0.9% saline and administered (50 mg/kg i.p.) immediately
following the last trial of the first block of training on days
5, 6 and 7 (Table 1). These 3 days were selected for the
injections because the primary objective of the experiment
was to explore putative changes in cell proliferation that
occurred during the period that the animals were learning
the spatial task. NST rats were injected at identical time
points. On day 10 of the experiment, the rats were deep-
ly anaesthetised with an overdose of pentobarbital sodium
(i.p.) and perfused transcardially with 40 ml of saline fol-
lowed by 140 ml of ice-cold paraformaldehyde (4% in
0.2 M sodium phosphate buffer, pH 7.4). The brain was
removed and postfixed in paraformaldehyde solution for
at least 24 h. Coronal sections (20 μm) were cut through-
out the hippocampus using a cryostat. Every eighth sec-
tion was thaw-mounted on slides.
Immunohistochemical techniques were used to identify
the cells that had incorporated BrdU during cell division. A
neuronal nuclear protein marker (NeuN) was used to help
visualise the neurones within the hippocampus and identify
the outer border of the granule cell layer. To maximise
antigen retrieval the following pretreatment steps were fol-
lowed: DNA denaturation was performed by incubating
the slides in 0.01 M citric acid (pH 6.0, 100°C, 10 min),
followed by membrane permeabilisation (0.01% trypsin in
0.1 M Tris/0.02 M CaCl2, 10 min) and acidification (2 M
HCl, 25°C, 30 min). The non-specific binding of prima-
ry antibodies was blocked by incubating the slides in the
blocking buffer, phosphate-buffered saline (PBS) contain-
ing 0.25% Triton X-100 and 10% normal horse serum
(PBST), for 1 h. The slides were then exposed to primary
antibodies: mouse-anti-NeuN (1:50; Chemicon Interna-
tional, UK) and rat-anti-BrdU (1:200; Harlan Sera-Lab,
UK) in PBST for 3 days at 4°C. Sections were then washed
in PBS for 10 min, blocked in PBST for 30 min and in-
cubated with secondary antibodies [fluorescein isothiocy-
anate (FITC)-labelled anti-mouse immunoglobulin G (IgG),
Scottish Antibody Production Unit (SAPU); 1:50 and tet-
ramethylrhodamine isothiocyanate (TRITC)-labelled anti-
rat IgG, SAPU; 1:160] for 1 h at room temperature. The
slides were then washed in PBS for 10 min, and after add-
ing a few drops of Vectorshield (Vector Laboratories, UK),
coverslips were placed on the slides and sealed with clear
nail varnish.
Slides were coded before counting to ensure objectivity.
BrdU-labelled cells were visualised using a fluorescent
microscope (Zeiss Axioskop II). Alternate sections were
selected for analysis. Hence, eight hippocampal sections
per rat were taken at intervals of 320 μm. All BrdU-
labelled cells within the granule cell layer and hilus of the
DG were counted, and the number of BrdU-labelled cells
for each subject was expressed as a mean per section
(Madsen et al. 2000).
Fig. 1 The effect of chronic nicotine infusions on the acquisition of
a spatial navigation task in the water maze. Escape latency values
(a) in rats receiving the high-dose nicotine (HDN, n=5) infusion
were significantly higher during day 4 of training compared to that
of control (Control, n=12) and low-dose nicotine (LDN, n=6). Swim
speed values (b) were not significantly different among the groups
for day 4 or any other training day. Results are shown as mean +
SEM (*P<0.05 for HDN compared to the control group by
Dunnett’s t test). Arrows on x-axis indicate when BrdU was ad-
ministered. c Diagrammatic representation of the pool quadrants
with the two possible platform locations (NE and SW, closed circles)
and the eight possible start locations
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Data analysis
All data were analysed using the Statistical Package for
Social Sciences (SPSS, version 11.5), and the level of
statistical significance was taken as P<0.05. Analysis of
variance (ANOVA) with repeated measures was used to
determine group differences in behavioural performance,
both during the acquisition of the spatial learning task and
during the probe trial. The percentage time spent in each
training quadrant was not independent, and therefore,
the numerator degree of freedom was reduced by one.
Post hoc analysis was carried out using further ANOVA
or Dunnett’s multiple comparisons. Group differences in
BrdU-labelled cells in the DG were analysed using two-
way ANOVA and post hoc using Dunnett’s t tests.
Results
Effect of nicotine on the spatial learning task
A preliminary inspection of individual acquisition curves
revealed that one rat in the HDN group did not improve
significantly over the eight blocks of trials. The mean
latency for this rat was more than two standard deviations
from the group mean on the last block of training, and the
results for this rat were therefore removed prior to analy-
sis of the data. All treatment groups showed a general
decrease in escape latency over training blocks, and re-
peated-measures ANOVA revealed significant effects of
days [F(3,60)=140, P<0.001] and blocks [F(1,20)=54.3,
P<0.001]. The LDN group appeared to find the platform
faster than control animals over training days 1 and 2,
whereas the HDN group appeared to take longer to find the
platform especially on days 2 and 4 of training (Fig. 1a).
There was a significant group by day interaction [F(6,60)=
2.45, P<0.05], and further analysis of each day revealed
that the groups only differed significantly on day 4 [F
(2,22)=4.37, P<0.05]. Post hoc pairwise comparisons con-
firmed that the HDN, but not the LDN, rats took longer
than controls (Dunnett’s t, P<0.05). The decrease in escape
latency over the early days in the LDN group did not reach
statistical significance. Analysis of the swim speed data
(Fig. 1b) revealed that there was no significant group by
day interaction [F<1], suggesting that the group difference
on the latency measure was not due to changes in swim
speed.
Analysis of the percentage time spent in each quadrant
during the probe trial suggested that while C and LDN rats
showed a preference for the quadrant where the platform
was located during training, the HDN rats did not (data not
shown). Statistical analysis revealed a significant quadrant
Fig. 2 The influence of chronic
nicotine and spatial learning on
the number of BrdU-labelled
cells in the DG. High-dose nic-
otine (HDN, n=5) infusion, but
not the low-dose (LDN, n=6),
reduced the number of BrdU
cells in both trained (ST) and
untrained (NST) rats compared
to control (Ctl, n=12). Exposure
to the spatial learning task sig-
nificantly increased the number
of BrdU-labelled cells indepen-
dently of treatment. Results
are shown as mean + SEM
(*P<0.05 compared to control
by Dunnett’s t test). Inset above:
Representative black and white
photomicrographs in a section
of the DG showing cells labelled
for BrdU (Scale bar 50 μm)
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by treatment interaction [F(5,60)=3.22, P=0.05], and sub-
sequent analysis of each group showed a highly signifi-
cant quadrant effect in the control group [F(2,33)=24.3,
P<0.001] and LDN group [F(2,15)=7.96, P<0.05] but
not the HDN group [F(2,12)=1.85, P>0.1]. Analysis of
the training quadrant alone confirmed a significant effect
of group [F(2,20)=3.93, P<0.05], with only HDN rats
spending significantly less time than controls in the re-
gion where the platform had been located (Dunnett’s t, P<
0.05). Statistical analysis of the annulus crossings also re-
vealed a highly significant quadrant by treatment interac-
tion [F(6,60)=2.6, P<0.05], and post hoc analyses of each
group confirmed a similar pattern, with only the HDN
group failing to show a significant bias for the platform
location.
Effect of nicotine infusion on BrdU incorporation
Spatial learning increased the number of BrdU-labelled
cells in the DG in all groups relative to rats not receiving
the task (Fig. 2). Administration of the higher nicotine dose
appeared to reduce BrdU-labelled cells both in trained and
non-trained animals. Statistical analysis revealed both a
significant task [F(1,40)=26.87, P<0.001] and treatment
[F(2,40)=20.44, P<0.001] effect, but no interaction be-
tween the two factors [F(2,40)=1.19, P>0.1]. Post hoc
analysis of the treatment effect confirmed that only the
high dose of nicotine reduced the number of cells pro-
duced compared to controls (P<0.05).
Discussion
This study has shown that the constant infusion of the
higher dose of nicotine (4 mg kg−1 day−1) evoked a modest
impairment of the acquisition of a spatial learning task and
significantly impaired retention of spatial memory when
tested with a probe trial. This contradicts other studies that
have reported nicotine-induced enhancements of cognitive
function in experimental models such as the radial maze
and water maze tasks (Decker et al. 1992; Socci et al. 1995;
Levin and Torry 1996; Levin and Rezvani 2000; Rezvani
and Levin 2001; Levin 2002; Hahn et al. 2002). By con-
trast, there have been reports that nicotine can also cause
impairments of learning and memory in these models
(Dunnett and Martel 1990) or have no effect (Hagan et al.
1989; Attaway et al. 1999). Furthermore, a recent study
reported that heavy smoking resulted in impaired cognitive
function measured in mid-life (Richards et al. 2003). Thus,
the response to nicotine seems to depend critically upon
factors such as the test employed, the dose of the drug
administered and the route of administration.
The effects of nicotine in this task were influenced by the
nicotine dose used, the deficits only being observed in
animals treated with the higher dose. Indeed, during the
early phase of training, the lower dose of nicotine tested
tended to enhance the acquisition of the task, although this
did not achieve statistical significance. While the reason for
the differences in response to the two doses tested remains
to be established, other studies in this laboratory have also
revealed differential effects of the drug when it was infused
at 0.25 or 4 mg kg−1 day−1. Specifically, the infusion of
nicotine at a rate of 4 mg kg−1 day−1 caused desensitisation
of the population of neuronal nicotinic receptors that me-
diate the effects of nicotine on dopamine release in the
nucleus accumbens and dorsal striatum as well as nor-
adrenaline release in the hippocampus (Benwell et al.
1995). By contrast, infusions of the lower dose tested
(0.25 mg kg−1 day−1) did not desensitise these receptors
and, indeed, resulted in sensitisation of this response in
animals subsequently challenged acutely with a single dose
of nicotine (Benwell et al. 1995). Inasmuch as it has been
investigated, intermediary doses of the drug also caused
desensitisation of neuronal nicotinic receptors in the rat
brain (Benwell et al. 1995; Pidoplichko et al. 1997; Balfour
et al. 2000). Thus, the constant infusion of nicotine at
the two doses investigated here have been shown to exert
differential effects in the brain in a manner which suggests
that they interact differentially with the diverse populations
of neuronal nicotinic receptor that mediate the psycho-
pharmacological responses to the drug. It can be hypoth-
esised that the deficit in spatial memory observed in the
present study may only be detected in animals in which
many of the neuronal nicotinic receptors are desensitised.
Many studies that have demonstrated beneficial effects
of nicotine on learning have employed intermittent in-
jections of the drug administered briefly before each test
(Decker et al. 1992; Socci et al. 1995; Curzon et al. 1996;
Hahn et al. 2002). This route of administration can be ex-
pected to stimulate the nicotinic receptors through which
nicotine exerts its effects in the brain, whereas the infusions
are more likely to result in desensitisation. This conclusion
is supported by the fact that intermittent injections of nic-
otine stimulate the mesolimbic and nigrostriatal dopami-
nergic pathways and the noradrenergic projections to the
hippocampus, whereas concomitant infusion of nicotine
blocks these responses (Benwell and Balfour 1997). This
study suggests that the constant infusion of nicotine at a
dose that generates similar plasma levels to intermittent
injections (e.g. ∼0.3 mg/kg s.c.) (Turner 1975) has different
effects on learning because its predominant effect is the
desensitisation of neuronal nicotinic receptors.
The constant infusion of the higher dose of nicotine also
inhibited BrdU incorporation into cells in the DG, whereas
the lower dose did not have a significant effect. Abrous
et al. (2002) also reported that the self-administration of
high doses of nicotine (0.04 or 0.06 mg kg−1 infusion−1)
reduced cell proliferation in the DG. This effect of self-
administered nicotine was restricted to the DG and did not
occur in the subventicular zone. By contrast, in mice, the
constant infusion of nicotine decreased BrdU incorpora-
tion into the granule cell layer of the olfactory bulb, but
had no significant effect in the DG (Mechawar et al. 2004).
The reason for the difference in the effects remains un-
clear, although the conditions of the experiment and the
species studied were clearly different.
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Training in the water maze task was associated with a
significant increase in BrdU incorporation into the DG. A
recent study has suggested that increased cell proliferation
in the DG is a feature of the later stages of water maze
learning (Dobrossy et al. 2003). However, Dobrossy et al.
(2003) used a single four-trial training block per day,
whereas in this study, 2×4 trial training blocks per day were
used. Therefore, it seems reasonable to assume that fewer
days would be required for the animals to reach the later
phase of learning, as supported by the observation that the
animals approached asymptotic performance by day 3 of
training. It is tempting to suggest that the nicotine-induced
deficits in learning, evidenced by impaired performance in
the probe trial, may be causally related to its effects on cell
proliferation in the hippocampus. However, this conclusion
should be treated with caution, since nicotine suppressed
the incorporation of BrdU in both untrained and maze-
trained animals. Thus, although maze-trained animals dis-
played a lower level of BrdU incorporation when treated
with nicotine as opposed to saline, cell genesis in both
saline- and nicotine-treated animals appeared to be elevated
to approximately the same extent by training.
There is evidence that cell proliferation in the hippo-
campus may also be enhanced by increased motor activity
(van Praag et al. 1999). It is possible that changes in BrdU
incorporation into the DG in rats trained in the maze could
be caused by the increase in motor activity associated with
daily training. This is unlikely to provide a complete ex-
planation for the data, since Dobrossy et al. (2003) dem-
onstrated that yoked rats, allowed to swim in the pool for
the same time as rats trained to locate an escape platform,
did not show the increase in neurogenesis observed in the
trained animals.
Nicotine, when administered at high doses, is reported to
have anxiogenic properties (File et al. 1998; File et al.
2000). Stressful stimuli are also reported to inhibit neu-
rogenesis in the hippocampus (Gould et al. 1997). Thus, it
is possible that the effects of the higher dose of nicotine on
BrdU incorporation in the DG could reflect anxiogenic
effects of nicotine. However, studies that demonstrated an
anxiogenic response to nicotine employed subcutaneous
injections of the drug. In the present investigation, nicotine
given by slow infusion from a subcutaneous mini pump
avoids the high peak in nicotine evoked by subcutaneous
injections of the drug. Furthermore, previous studies in our
laboratory have shown that nicotine infused at 4 mg kg−1
day−1 did not elicit an anxiogenic response in the elevated
plus maze (Benwell et al. 1994). The same dose had no
significant effects on the plasma corticosterone concen-
tration in control, unstressed animals or the raised cortico-
sterone levels found in animals exposed acutely to the
elevated plus-maze test (Benwell et al. 1994). These results
imply that the chronic administration of nicotine by this
route does not, in itself, evoke a stress response, nor does
it influence the response to an anxiogenic stimulus, such
as the plus-maze.
In conclusion, this study has shown that the constant
infusion of nicotine at a dose that is likely to cause desen-
sitisation of many of the neuronal nicotinic receptors in the
brain reduces BrdU incorporation into the DG and impairs
acquisition of a water maze task. However, the nicotine
infusions did not exert a selective effect on BrdU incor-
poration in the rats tested in the water maze. As a result,
further studies are required before reaching a conclusion
regarding a causal relationship between reduced BrdU in-
corporation and impaired spatial learning and alternative
behavioural sequelae cannot be excluded.
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